Chemical chaperone rescue of mutant human cystathionine -synthase
Time to Progression to Castration-Resistant Prostate Cancer After Commencing Combined Androgen Blockade for Advanced Hormone-Sensitive Prostate Cancer
All patients ( n = 209) with MM ( n = 41), NSCLC ( n = 91), urothelial cell carcinoma ( n = 8), renal cell carcinoma ( n = 21), head and neck cancer ( n = 28), gastric cancer ( n = 19) or Hodgkin lymphoma ( n = 1) treated with pembrolizumab or nivolumab between November 2, 2015 and October 31, 2018 at Nagoya University Hospital were included in this study, and observed until death or referral to another hospital
RFID:Image ID:2BCW6PK Image details Contributor: molekuul.be Image ID: 2BCW6PK File size: 40.2 MB (1.1 MB Compressed download) Releases: Model - no | Property - noDo I need a release
A retirada do consentimento no afeta a licitude do tratamento efetuado antes dessa retirada
April 2025: Novo Nordisk committed USD 1.09 billion to expand Montes Claros fill-finish capacity, with operations slated for late 2026